Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

Authors: Michael J. Fisher, Chie-Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan K. Bessler, Yongzheng He, Su-Jung Park, Julie A. Mund, Li Jiang, Khadijeh Bijangi-Vishehsaraei, Coretta Thomas Robinson, Gary R. Cutter, Bruce R. Korf, , Chie-Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp

Published: 2021-01-13

DOI: 10.1038/s41591-020-01193-6

Source: Full article


Abstract

No abstract found.